US Patent 7576062 Compounds with growth hormone releasing properties
Patent 7576062 was granted and assigned to Novo Nordisk on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+51 characters)
Article
Patent abstract
Disclosed are compounds of formula I
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07576062 Compounds with growth hormone releasing properties US Patent 7576062 Compounds with growth hormone releasing properties
Infobox
Patent Number
0757606200
Patent Number
757606200
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075760620
Date of Patent
August 18, 2009
0Patent Application Number
111470170
Date Filed
June 7, 2005
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075760620
Date of Patent
August 18, 2009
0Patent Application Number
111470170
Date Filed
June 7, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07576062 Compounds with growth hormone releasing properties
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07576062
Date of patent
August 18, 2009
Patent application number
11147017
Date Filed
June 7, 2005
Patent primary examiner
Find more entities like US Patent 7576062 Compounds with growth hormone releasing properties
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.